FDA Approves Omvoh for Moderately to Severely Active Crohn Disease
THURSDAY, Jan. 16, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn dis…
More from Mississippi Coast
WXXV 25
Boys and Girls Club of the Gulf Coast hosting 'Taste of the Future' benefit
Mississippi Coast
•
5h ago
WXXV 25
US markets are weighed down by an extended sell-off in the tech sector
Mississippi Coast
•
6h ago
WXXV 25
Retail sales up 0.8% in September, but a big chunk of spending went to paying gasoline bills
Mississippi Coast
•
6h ago